Sound waves and immunotherapy: a new combo against breast cancer?
Disease control
Terminated
This early study tested whether using high-intensity focused ultrasound (HIFU) before or after the immunotherapy drug pembrolizumab could help the immune system better attack metastatic breast cancer. Only 13 people took part before the study was stopped early. The main goal was …
Phase: PHASE1 • Sponsor: Patrick Dillon, MD • Aim: Disease control
Last updated May 26, 2026 04:37 UTC